Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.71	5.38	8.49	11.78	24.06	14.24
Cash & Short-Term Investments	10.71	5.38	8.49	11.78	24.06	14.24
Cash Growth	98.61%	-36.61%	-27.93%	-51.03%	68.89%	105.42%
Prepaid Expenses	0.79	0.35	0.83	0.62	0.62	0.87
Restricted Cash	-	-	-	0.05	0.05	0.05
Total Current Assets	11.49	5.74	9.32	12.45	24.73	15.16
Property, Plant & Equipment	0.01	0	0.04	0.34	0.42	0.56
Other Long-Term Assets	-	-	0	0.02	0.03	0.02
Total Assets	11.51	5.74	9.36	12.81	25.17	15.74
Accounts Payable	0.52	0.25	0.66	0.78	0.28	0.73
Accrued Expenses	1.15	0.76	0.94	1.01	2.66	1.25
Current Portion of Leases	-	-	0.04	0.14	0.13	0.12
Other Current Liabilities	-	-	-	0.02	-	0.1
Total Current Liabilities	1.67	1.02	1.63	1.94	3.07	2.2
Long-Term Debt	-	-	-	-	-	0.23
Long-Term Leases	-	-	-	0.04	0.17	0.3
Total Liabilities	1.67	1.02	1.63	1.97	3.24	2.72
Common Stock	0	-	-	-	-	0
Additional Paid-In Capital	162.52	151.08	146.94	139.22	138.83	116.63
Retained Earnings	-152.68	-146.36	-139.21	-128.38	-116.9	-103.61
Total Common Equity	9.84	4.72	7.73	10.84	21.93	13.02
Shareholders' Equity	9.84	4.72	7.73	10.84	21.93	13.02
Total Liabilities & Equity	11.51	5.74	9.36	12.81	25.17	15.74
Total Debt	-	-	0.04	0.17	0.3	0.64
Net Cash (Debt)	10.71	5.38	8.46	11.61	23.76	13.6
Net Cash Growth	98.61%	-36.34%	-27.18%	-51.14%	74.69%	112.00%
Net Cash Per Share	2.72	6.83	36.52	91.94	200.01	320.24
Filing Date Shares Outstanding	10.76	4.78	0.51	0.13	0.13	0.13
Total Common Shares Outstanding	5.78	1.73	0.42	0.13	0.13	0.05
Working Capital	9.83	4.72	7.69	10.51	21.66	12.97
Book Value Per Share	1.70	2.72	18.57	85.64	175.00	243.18
Tangible Book Value	9.84	4.72	7.73	10.84	21.93	13.02
Tangible Book Value Per Share	1.70	2.72	18.57	85.64	175.00	243.18
Machinery	-	0.31	1.1	1.31	1.19	1.23
Leasehold Improvements	-	-	0.05	0.05	0.05	0.05

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q